Skip to main content

Ari Melnick, MD

New York, NY
United States

Weill Cornell Medicine

Ari M. Melnick, MD, is Gebroe Family Professor of Hematology/Oncology in the Departments of Medicine and Pharmacology at the Weill Cornell Medical College in NYC. He is chair of the Hematologic Malignancies Program of the Weill Cornell Cancer Center, Director of the Sackler Center for Biomedical and Physical Sciences at Weill Cornell. He has authored or co-authored more than 250 manuscripts in journals such as Nature, Science, Cell, Cancer Cell, Nature Medicine, Nature Immunology and the New England Journal of Medicine. Dr. Melnick’s research is focused on discovering transcriptional and epigenomic mechanisms that drive lymphoid and myeloid neoplasms and harnessing these mechanisms for development of novel drugs and therapeutic regimens for cancer patients. He performed the first organized and comprehensive epigenome mapping in human disease. These studies have expanded to include an international network and over 3000 patients enrolled in various large-scale clinical trials.

Program Name(s)
Special Grants
Ari Melnick